Monash@70 Fellowship for Hudson Institute Centre Head

By Rob Clancy, staff writer. Reviewed by Professor Seth Masters

Professor Seth Masters Monash 70 fellowship
Professor Seth Masters

The head of Hudson Institute’s Centre for Innate Immunity and Infectious Diseases (CiiiD), Professor Seth Masters, has been named among the first recipients of the Monash 70th Anniversary Fellowships.

The first list of fellows was announced today, to recognise and celebrate the University’s most outstanding academic staff for their sustained contributions which have shaped its success and continue to drive its global significance.

Up to 70 Fellows will be awarded across three categories – Education, Research, and Commercialisation and Enterprise – recognising sustained excellence and leadership in areas critical to the University’s continued success.

These awards are for staff who are not only excellent in their everyday work but whose performance goes above and beyond their role – they demonstrate significant initiative and act as leaders who connect to, lift up, and look out for others.

Prof Masters was thrilled to be recognised in this Monash@70 initiative.

“It’s wonderful to be part of an organisation that features leaders across a diverse spectrum, through which a new generation are being fostered,” he said.

“Monash University, Hudson Institute and Monash Health make for a wonderful work environment, in which discoveries can be made and then directly impact patients.

“Monash@70 provides me with a platform to encourage others to join in this endeavour and take these advances further out into the world.” 

These Monash Fellowships come with a one-off financial reward and a title which will be used over the three-year term.

About Hudson Institute

Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More

Hudson News

Get the inside view on discoveries and patient stories

and also

“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”

Alana Chantry